Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management and treatment of breast cancer.
Funds vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.
We are passionate and determined to improve heart health and beat heart disease through advances in knowledge and research.
Our aim is to reduce and ultimately eliminate the high incidence of chronic kidney disease and diabetes in Australia and around the world.
Supports health and wellbeing research for veterans, emergency service personnel and their families.
Driving collaboration, innovation and research to develop best-practice arts, design and health programs.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
The proud recipient of The Hospital Research Foundation’s Mid-Career Fellowship for 2017, geographer and researcher Dr Danielle Taylor is kick-starting a three year project aimed at ensuring our community can live longer, healthier and more fulfilling lives in the comfort of their own homes. read more
We caught up with Dr Rachel Dreyer back in 2015 who is researching after she moved to Yale University Centre for Outcomes Research and Evaluation in the United States and we have an exciting update to share! Dr Dreyer has just received a promotion through Yale School of Medicine and is eager to share her latest research with us! read more
Ground-breaking research is underway boosting the body’s own immune system to fight the most common cancers affecting Australian families, including breast cancer. The treatment is known as immunotherapy, and whilst it’s currently revolutionising blood cancer treatment, when it comes to solid cancers like breast cancer it’s not known to be as effective. read more
Three years ago Katharina Richter started her PhD with a determination to improve the lives of people living with a debilitating condition, Chronic Rhinosinusitis (CRS). We’re very pleased to share that she’s achieved just that! read more
We are excited to give you an update on clinical trainee Ben Thurston, who last year won the prize for best clinical trainee presentation at the annual Basil Hetzel Institute for Translational Health Research (BHI) Research Day. read more
Leaving her position as a geriatrician in Brazil, Dr Beatriz Arakawa Martins came to Adelaide in 2016 in search of answers on a condition impacting the quality of life of our ageing population – frailty. Specifically, Dr Martins wants to understand the role our home environment plays in the development of frailty in our community. read more
A potential breakthrough between breast cancer and bone regeneration could significantly help manage the spread of cancer-related bone destruction and improve quaility of life. read more
Khamis Tomusange has one big dream – to bring an end to the current global HIV pandemic.
Supported by The Hospital Research Foundation (THRF), Khamis is working tirelessly to make his dream a reality. read more
Receiving The Hospital Research Foundation Mid-Career Research Fellowship last year was the beginning of an exciting adventure for Dr Doan Ngo, who is now leading world-first research into a protein they have confirmed correlates with the natural process of the heart increasing in size as we age. read more
Based at the Basil Hetzel Institute for Translational Health Research (BHI), breast cancer researcher Irene Zinonos is now part of a collaborative word-first prostate cancer research project. Led by the University of Adelaide’s Associate Professor Lisa Butler, this project aims to help quickly identify life-threatening cases of prostate cancer, compared with cancer that may not require treatment. read more